Literature DB >> 9189862

Overexpression of GLUT2 gene in renal proximal tubules of diabetic Zucker rats.

M Kamran1, R G Peterson, J H Dominguez.   

Abstract

Renal tubular reabsorption of glucose is substantially increased in humans and rats with diabetes mellitus. The influx of luminal glucose is mediated by Na+/glucose cotransporter system and glucose efflux from tubules to interstitium by facilitative glucose transporters (GLUT). In Zucker diabetic rats, GLUT2 protein levels of renal proximal tubules were higher than in control litter mates: 9.67 +/- 1.95 versus 4.72 +/- 1.55 (P = 0.0073). In the same proximal tubules, diabetes was associated with minor decreases in GLUT1 protein levels: 1.96 +/- 0.37 for diabetics and 2.37 +/- 0.34 for controls (P = 0.12). Na+/glucose cotransporter system protein levels were similar in both groups, whereas Na+/K+ ATPase levels were slightly decreased in diabetic rats, but the difference was not statistically significant. In this report, it is suggested that in long-term uncontrolled diabetes, GLUT2 transporters are overexpressed in renal tubules. This adaptation promotes low-affinity, high-capacity glucose efflux. The higher number of high K(m) GLUT2 ensures that glucose reabsorption is increased by promoting glucose efflux, which could be rate-limiting in the face of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189862     DOI: 10.1681/ASN.V86943

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  A fluorescence method for measurement of glucose transport in kidney cells.

Authors:  Amy B Blodgett; Rajendra K Kothinti; Ivan Kamyshko; David H Petering; Suresh Kumar; Niloofar M Tabatabai
Journal:  Diabetes Technol Ther       Date:  2011-04-21       Impact factor: 6.118

Review 2.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 3.  Coming full circle in diabetes mellitus: from complications to initiation.

Authors:  Brooke E Harcourt; Sally A Penfold; Josephine M Forbes
Journal:  Nat Rev Endocrinol       Date:  2013-01-08       Impact factor: 43.330

4.  Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.

Authors:  Liad Hinden; Shiran Udi; Adi Drori; Asaad Gammal; Alina Nemirovski; Rivka Hadar; Saja Baraghithy; Anna Permyakova; Matan Geron; Merav Cohen; Sabina Tsytkin-Kirschenzweig; Yael Riahi; Gil Leibowitz; Yaakov Nahmias; Avi Priel; Joseph Tam
Journal:  J Am Soc Nephrol       Date:  2017-10-13       Impact factor: 10.121

Review 5.  Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-09

Review 6.  The proximal tubule in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

Review 7.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

8.  Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane.

Authors:  Joanne Marks; Nicolas J C Carvou; Edward S Debnam; Surjit K Srai; Robert J Unwin
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

Review 9.  Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.

Authors:  Panai Song; Akira Onishi; Hermann Koepsell; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2016-04-12       Impact factor: 6.902

Review 10.  The tubular hypothesis of nephron filtration and diabetic kidney disease.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Nat Rev Nephrol       Date:  2020-03-09       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.